新FIGO分期标准诊治的86例子宫内膜癌病例结果分析  

Analysis of 86 cases of endometrial cancer diagnosed and treated by new FIGO staging system

作　　者：彭广兰[1] 周家德[1] 张媛媛[1] 

机构地区：[1]安徽医科大学第一附属医院妇产科,合肥230022

出　　处：《安徽医学》2012年第12期1642-1645,共4页Anhui Medical Journal

摘　　要：目的探讨子宫内膜癌新分期标准的意义及临床诊治问题。方法对86例子宫内膜癌患者手术前后临床资料进行回顾性分析。结果 86例内膜病变手术前后分期及病理符合率分别为55.8%、75.6%;ⅠA期与ⅠB及以上期别、内膜样癌与非内膜样癌病例血清中CA125阳性率间的差异有统计学意义(P<0.05),腹水细胞学阳性率间的差异无统计学意义(P>0.05);本研究分组间淋巴结阳性率的差异均无统计学意义(P>0.05)。结论对子宫内膜癌(尤其是术前诊断为Ⅰ期)患者进行系统的分期手术,不仅弥补了术前诊断的不准确性,避免遗漏IIIC期患者,也更符合新手术-病理分期标准的要求。Objective To assess the significance of new FIGO staging system of endometrial cancer and discuss the problems during its diagnosis and treatment. Methods The preoperative and postoperative clinical - pathological materials of 86 cases of endometrial cancer were retrospectively studied. Results The coincidence rate of tumor staging and pathology of all the cases before and after operation was 55. 8% ,75.6% , respectively. The difference of CA125 positive rate between stage I A and overtop the stage was statistically significant （P 〈 0. 05 ）, and the same result was obtained between endometrial adenocarcinoma and other pathological types. Meanwhile, there were no statistical differences between the two groups in terms of peritoneal dropsy positive rates （P 〉 0.05 ）. The differences of metastatic lymph node ratio among groups of the study were not statistically significant （P 〉 0.05 ）. Conclusion Systematic staging operation should be carried out on patients with endometrial cancer, especially preoperative diagnosed stage I , which not only remedies the inaccuracy of preoperative diagnosis, but also meets the new staging system＇s requirements preferablv.

关 键 词：子宫内膜癌 分期 病理类型 CA125 腹水细胞学 

分 类 号：R737.33[医药卫生—肿瘤]